ASX Share rice
Sun 09 Aug 2020 - 06:36:pm (Sydney)

PNV Share Price

POLYNOVO LIMITEDPNVHealth Care Equipment & Services

PNV Company Information

Name:

PolyNovo Limited

Sector:

Healthcare

Industry:

Biotechnology

GIC Industry:

Biotechnology

GIC Sub Industry:

Biotechnology

Address:

320 Lorimer Street Port Melbourne VIC Australia 3207

Phone:

61 3 8681 4050

Full Time Employees:

65

CEO, MD & Director:

Mr. Paul Brennan

CFO & Company Sec.:

Mr. Jan-Marcel Gielen C.A.

Director of Operations:

Mr. Gordon Fleming

Marketing & Distributor Mang.:

Ms. Katherine Napier

HR Mang.:

Ms. Monica Benyk

Company Overview:

Polynovo Limited, a medical device company, designs, develops, and manufactures dermal regeneration solutions in the United States, Australia, New Zealand, and internationally. The company focuses on the development and commercialization of medical devices using its NovoSorb technology in the treatment of burns, surgical wounds, and negative pressure wound therapy. It offers BTM (biodegradable temporising matrix), a wound dressing intended for treatment of full-thickness wounds and burns. In addition, Polynovo Limited licensed its NovoSorb to Smith & Nephew for orthopaedic applications. The company was formerly known as Calzada Limited and changed its name to Polynovo Limited in November 2014. Polynovo Limited is based in Port Melbourne, Australia.

PNV Share Price Information

Shares Issued:

661.09M

Market Capitalisation:

$1.46B

Revenue (TTM):

$18.56M

Revenue Per Share (TTM):

$0.03

Earnings per Share:

$-0.005

Profit Margin:

-0.1989

Operating Margin (TTM):

$-0.20

Return On Assets (TTM):

$-0.08

Return On Equity (TTM):

$-0.14

Quarterly Revenue Growth (YOY):

0.797

Gross Profit(TTM):

$9.50M

Diluted Earnings Per Share (TTM):

$-0.006

PNV CashFlow Statement

CashFlow Date:

2019-06-30

Investments:

$13.06M

Change To Liabilities:

$1.57M

Total Cashflow From Investing Activities:

$13.06M

Net Income:

$-3,189,893

Total Cash From Operating Activities:

$-3,369,733

Depreciation:

$691.03K

Other Cashflow From Investing Activities:

$581.57K

Change To Inventory:

$-962,522

Change To Account Receivables:

$-1,007,641

Capital Expenditures:

$6.52M

PNV Income Statement

Income Date:

2019-06-30

Income Before Tax:

$-3,189,893

Net Income:

$-3,189,893

Gross Profit:

$12.06M

Operating Income:

$-4,563,814

Other Operating Expenses:

$300.99K

Total Revenue:

$13.35M

Total Operating Expenses:

$16.62M

Cost Of Revenue:

$1.29M

PNV Balance Sheet

Balance Sheet Date:

2019-06-30

Intangible Assets:

$2.15M

Total Liabilities:

$2.13M

Total Stockholder Equity:

$26.10M

Other Current Liabilities:

$1.17M

Total Assets:

$28.23M

Common Stock:

$139.07M

Other Current Assets:

$442.41K

Retained Earnings:

$-106,459,114

Other Liabilities:

$65.04K

Other Assets:

$170.77K

Cash:

$13.92M

Total Current Liabilities:

$2.06M

Property - Plant & Equipment:

$6.01M

Net Tangible Assets:

$23.95M

Long-Term Investments:

$170.77K

Total Current Assets:

$19.90M

Net Receivables:

$2.48M

Short-Term Investments:

$8.33M

Inventory:

$1.22M

Accounts Payable:

$581.70K

Non Currrent Assets (Other):

$8.33M

Short-Term Investments:

$8.33

Non Current Liabilities (Other):

$17.30K

Non Current Liabilities Total:

$65.04K

PNV Share Price History

PNV News

19 May, 2020
It hasn't been the best quarter for PolyNovo Limited (ASX:PNV) shareholders, since the share price has fallen 19% in...
10 Apr, 2020
In 2015 Paul Brennan was appointed CEO of PolyNovo Limited (ASX:PNV). First, this article will compare CEO...
27 Jan, 2020
We often see insiders buying up shares in companies that perform well over the long term. On the other hand, we'd be...
12 Dec, 2019
There's no doubt that money can be made by owning shares of unprofitable businesses. By way of example, PolyNovo...
28 Oct, 2019
Long term investing can be life changing when you buy and hold the truly great businesses. And we've seen some truly...
19 Sep, 2019
Paul Brennan became the CEO of PolyNovo Limited (ASX:PNV) in 2015. This analysis aims first to contrast CEO...
14 Aug, 2019
Every investor in Polynovo Limited (ASX:PNV) should be aware of the most powerful shareholder groups. Generally...